MAPT and supranuclear palsy, progressive, 1: Our study aim was to assess the relationship of underlying tau neuropathology in disease-specific regions to the in vivo MRI volume loss and white matter tract abnormalities in a cohort of 47 autopsy-confirmed patients with a 4R tauopathy, including PSP and CBD.